ATE530561T1 - 3-ether- und 3-thioether-substituierte ciclosporinderivate zur behandlung und prävention einer hepatitis-c-infektion - Google Patents
3-ether- und 3-thioether-substituierte ciclosporinderivate zur behandlung und prävention einer hepatitis-c-infektionInfo
- Publication number
- ATE530561T1 ATE530561T1 AT05815625T AT05815625T ATE530561T1 AT E530561 T1 ATE530561 T1 AT E530561T1 AT 05815625 T AT05815625 T AT 05815625T AT 05815625 T AT05815625 T AT 05815625T AT E530561 T1 ATE530561 T1 AT E530561T1
- Authority
- AT
- Austria
- Prior art keywords
- hepatitis
- treatment
- derivatives
- ciclosporine
- infection
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US61515204P | 2004-10-01 | 2004-10-01 | |
US70762605P | 2005-08-11 | 2005-08-11 | |
PCT/US2005/035533 WO2006039668A2 (en) | 2004-10-01 | 2005-09-30 | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE530561T1 true ATE530561T1 (de) | 2011-11-15 |
Family
ID=36143148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT05815625T ATE530561T1 (de) | 2004-10-01 | 2005-09-30 | 3-ether- und 3-thioether-substituierte ciclosporinderivate zur behandlung und prävention einer hepatitis-c-infektion |
Country Status (20)
Country | Link |
---|---|
US (2) | US20100167996A1 (de) |
EP (1) | EP1802650B1 (de) |
JP (2) | JP5139065B2 (de) |
KR (1) | KR101309409B1 (de) |
CN (1) | CN101773661B (de) |
AT (1) | ATE530561T1 (de) |
AU (1) | AU2005292162B2 (de) |
BR (1) | BRPI0516737A (de) |
CA (1) | CA2583494C (de) |
DK (1) | DK1802650T3 (de) |
ES (1) | ES2373450T3 (de) |
HK (1) | HK1108703A1 (de) |
IL (1) | IL182315A (de) |
MX (1) | MX2007003538A (de) |
NZ (1) | NZ554514A (de) |
PL (1) | PL1802650T3 (de) |
PT (1) | PT1802650E (de) |
RU (1) | RU2399628C2 (de) |
SI (1) | SI1802650T1 (de) |
WO (1) | WO2006039668A2 (de) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7196161B2 (en) | 2004-10-01 | 2007-03-27 | Scynexis Inc. | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection |
ES2314731T3 (es) | 2004-11-22 | 2009-03-16 | Astellas Pharma Inc. | Analogo de ciclosporina. |
EP1933859A2 (de) * | 2005-09-30 | 2008-06-25 | Scynexis, Inc. | Verfahren und pharmazeutische zusammensetzungen zur behandlung und prävention von hepatitis-c-infektionen |
WO2007041631A1 (en) | 2005-09-30 | 2007-04-12 | Scynexis, Inc. | ARYIiALKYL AND HETEROARYLALKYL DERIVATIVES OF CYCLOSPORINE A FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTION |
JP5218051B2 (ja) | 2005-10-26 | 2013-06-26 | アステラス製薬株式会社 | 新規環状ペプチド化合物 |
ES2543840T3 (es) | 2006-04-11 | 2015-08-24 | Novartis Ag | Inhibidores espirocíclicos del VHC/VIH y sus usos |
CN101511357B (zh) | 2006-05-19 | 2011-11-02 | 西尼克斯公司 | 环孢菌素类化合物及其组合物在制备治疗和预防眼部疾病的药物中的应用 |
EP2027761A1 (de) * | 2006-06-02 | 2009-02-25 | Claude Annie Perrichon | Verwaltung von aktieven elektronen |
CN101557819A (zh) * | 2006-10-12 | 2009-10-14 | 诺瓦提斯公司 | 修饰的环孢素的用途 |
WO2008069917A2 (en) | 2006-11-20 | 2008-06-12 | Scynexis, Inc. | Novel cyclic peptides |
US20080255038A1 (en) * | 2007-04-11 | 2008-10-16 | Samuel Earl Hopkins | Pharmaceutical compositions |
WO2008139986A1 (en) | 2007-05-02 | 2008-11-20 | Astellas Pharma Inc., | New cyclic peptide compounds |
WO2010002428A2 (en) * | 2008-06-06 | 2010-01-07 | Scynexis, Inc. | Novel macrocyclic peptides |
WO2009148615A1 (en) * | 2008-06-06 | 2009-12-10 | Scynexis, Inc. | Cyclosporin analogs and their use in the treatment of hcv infections |
US20130190223A1 (en) | 2008-07-30 | 2013-07-25 | Isotechnika Pharma Inc. | Nonimmunosuppressive cyclosporine analogue molecules |
CN102307892A (zh) * | 2008-12-31 | 2012-01-04 | 西尼克斯公司 | 环孢菌素a的衍生物 |
SG172848A1 (en) * | 2009-01-07 | 2011-08-29 | Scynexis Inc | Cyclosporine derivative for use in the treatment of hcv and hiv infection |
WO2010088573A1 (en) * | 2009-01-30 | 2010-08-05 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues for preventing or treating hepatitis c infection |
US8481483B2 (en) | 2009-02-19 | 2013-07-09 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
US8512690B2 (en) | 2009-04-10 | 2013-08-20 | Novartis Ag | Derivatised proline containing peptide compounds as protease inhibitors |
US20110182850A1 (en) | 2009-04-10 | 2011-07-28 | Trixi Brandl | Organic compounds and their uses |
US8685917B2 (en) | 2009-07-09 | 2014-04-01 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
US8349312B2 (en) | 2009-07-09 | 2013-01-08 | Enanta Pharmaceuticals, Inc. | Proline substituted cyclosporin analogues |
US8367053B2 (en) | 2009-07-09 | 2013-02-05 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues |
KR20120106942A (ko) | 2009-10-30 | 2012-09-27 | 베링거 인겔하임 인터내셔날 게엠베하 | Bi201335, 인터페론 알파 및 리바비린을 포함하는 hcv 병용 치료요법을 위한 투여 용법 |
EP2509615A1 (de) | 2009-12-09 | 2012-10-17 | Scynexis, Inc. | Neue cyclische peptide |
KR20120116404A (ko) * | 2009-12-18 | 2012-10-22 | 베링거 인겔하임 인터내셔날 게엠베하 | Hcv 병용 요법 |
CN102834409A (zh) | 2009-12-30 | 2012-12-19 | 西尼克斯公司 | 环孢菌素类似物 |
US8623814B2 (en) | 2010-02-23 | 2014-01-07 | Enanta Pharmaceuticals, Inc. | Antiviral agents |
US9217015B2 (en) | 2010-07-16 | 2015-12-22 | S&T Global Inc. | Cyclosporin derivatives for the treatment and prevention of a viral infection |
CN103153330B (zh) | 2010-08-12 | 2017-08-18 | 美国科技环球有限公司 | 新的环孢霉素衍生物在病毒感染的治疗和预防中的应用 |
BR112013008510A2 (pt) | 2010-10-08 | 2016-07-05 | Novartis Ag | vitamina e formulações de inibidores de sulfamida ns3 |
AU2011336266B2 (en) * | 2010-12-03 | 2017-04-06 | S&T Global Inc. | Novel cyclosporin derivatives for the treatment and prevention of a viral infection |
US9890198B2 (en) | 2010-12-03 | 2018-02-13 | S&T Global Inc. | Cyclosporin derivatives and uses thereof |
MX353720B (es) | 2010-12-15 | 2018-01-25 | Contravir Pharmaceuticals Inc | Moleculas analogas de ciclosporina modificadas en el aminoacido 1 y 3. |
RU2448690C1 (ru) * | 2011-03-15 | 2012-04-27 | Открытое акционерное общество "Биосинтез" | Твердая лекарственная форма пролонгированного действия нестероидного противовоспалительного средства кетопрофен, способ получения |
CN103987399A (zh) * | 2011-08-19 | 2014-08-13 | 美国科技环球有限公司 | 用于治疗和预防病毒感染的新型环孢菌素衍生物 |
CN104487449A (zh) | 2012-06-01 | 2015-04-01 | 阿勒根公司 | 环孢菌素a类似物 |
US8906853B2 (en) | 2012-11-28 | 2014-12-09 | Enanta Pharmaceuticals, Inc. | [N-Me-4-hydroxyleucine]-9-cyclosporin analogues for treatment and prevention of hepatitis C infection |
US20140205566A1 (en) | 2012-11-30 | 2014-07-24 | Novartis Ag | Cyclic nucleuoside derivatives and uses thereof |
KR20160045136A (ko) | 2013-08-26 | 2016-04-26 | 이난타 파마슈티칼스, 인코포레이티드 | C형 간염을 예방 또는 치료하기 위한 사이클로스포린 유사체 |
US9669095B2 (en) | 2014-11-03 | 2017-06-06 | Enanta Pharmaceuticals, Inc. | Cyclosporin analogues for preventing or treating hepatitis C infection |
US9914755B2 (en) | 2015-01-08 | 2018-03-13 | Allergan, Inc. | Cyclosporin derivatives wherein the MeBmt sidechain has been cyclized |
US10077289B2 (en) | 2015-03-31 | 2018-09-18 | Allergan, Inc. | Cyclosporins modified on the MeBmt sidechain by heterocyclic rings |
US10738084B2 (en) * | 2015-06-30 | 2020-08-11 | Sentry Therapeutics Limited | Macrocycles |
GB201711749D0 (en) * | 2017-07-21 | 2017-09-06 | Cypralis Ltd | Cyclosporin analogues and uses thereof |
WO2020037530A1 (en) | 2018-08-22 | 2020-02-27 | Waterstone Pharmaceuticals (Wuhan) Co., Ltd. | Crystalline form of compound and uses thereof in medicine |
US20230181680A1 (en) * | 2020-04-15 | 2023-06-15 | Farsight Medical Technology (Shanghai) Co., Ltd. | Prevention and treatment of organ injuries |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0194972B1 (de) * | 1985-03-11 | 1992-07-29 | Sandoz Ag | Cyclosporine |
US4814323A (en) * | 1986-03-25 | 1989-03-21 | Andrieu J M | Process for the treatment and the prevention of AIDS and other disorders induced by the LAV/HTLV III virus |
US4885276A (en) * | 1987-06-03 | 1989-12-05 | Merck & Co., Inc. | Cyclosporin analogs with modified "C-9 amino acids" |
US4798823A (en) * | 1987-06-03 | 1989-01-17 | Merck & Co., Inc. | New cyclosporin analogs with modified "C-9 amino acids" |
US4996193A (en) * | 1989-03-03 | 1991-02-26 | The Regents Of The University Of California | Combined topical and systemic method of administration of cyclosporine |
US5294604A (en) * | 1989-12-20 | 1994-03-15 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method of treating ocular diseases by periocular administration of cyclosporine A or G |
EP0484281B2 (de) * | 1990-11-02 | 2000-11-22 | Novartis AG | Zyklosporine |
AU683049B2 (en) * | 1993-03-31 | 1997-10-30 | Mitsubishi-Tokyo Pharmaceuticals, Inc. | Cholestasis ameliorant |
EP0773029A4 (de) * | 1993-07-19 | 1997-09-03 | Tokyo Tanabe Co | Inhibitor der hepatitis-c-virus-proliferation |
ATE209216T1 (de) * | 1995-07-17 | 2001-12-15 | Chem Ag C | Cyclosporin-derivate mit anti-hiv-wirkung |
JP3089350B2 (ja) * | 1995-11-20 | 2000-09-18 | ギルフォード ファーマシューティカルズ インコーポレイテッド | シクロフィリンロタマーゼ活性の阻害剤 |
FR2757521B1 (fr) * | 1996-12-24 | 1999-01-29 | Rhone Poulenc Rorer Sa | Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent |
FR2757522B1 (fr) * | 1996-12-24 | 1999-01-29 | Rhone Poulenc Rorer Sa | Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent |
FR2757520B1 (fr) * | 1996-12-24 | 1999-01-29 | Rhone Poulenc Rorer Sa | Derive de cyclosporine, sa preparation et les compositions pharmaceutiques qui le contiennent |
FR2762843B1 (fr) * | 1997-04-30 | 1999-12-10 | Rhone Poulenc Rorer Sa | Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent |
ATE254630T1 (de) * | 1998-06-12 | 2003-12-15 | Chem Ag C | Cyclosporine |
FR2780061B1 (fr) * | 1998-06-22 | 2001-09-07 | Rhone Poulenc Rorer Sa | Nouveau procede de preparation de derives de cyclosporine |
JP4350898B2 (ja) * | 1998-07-01 | 2009-10-21 | デビオファーム・ソシエテ・アノニム | 活性の特徴が改善された新規のシクロスポリン |
US6254860B1 (en) * | 1999-04-13 | 2001-07-03 | Allergan Sales, Inc. | Ocular treatment using cyclosporin-A derivatives |
US6521595B1 (en) * | 1999-11-19 | 2003-02-18 | Lg Chemical, Ltd. | Nonimmunosuppressive [γ-hydroxy-methylleucine4] cyclosporin A, hair growth stimulator and external composition for skin using the same |
US7012066B2 (en) * | 2000-07-21 | 2006-03-14 | Schering Corporation | Peptides as NS3-serine protease inhibitors of hepatitis C virus |
US6987090B2 (en) * | 2002-05-09 | 2006-01-17 | Lg Household & Health Care Ltd. | Use of 3-position cyclosporin derivatives for hair growth |
KR20040039622A (ko) * | 2002-11-04 | 2004-05-12 | 주식회사 엘지생활건강 | 모발 성장 효과를 갖는 사이클로스포린 3 위치 유도체를유효성분으로 하는 모발 성장 촉진제 |
GB0320638D0 (en) * | 2003-09-03 | 2003-10-01 | Novartis Ag | Organic compounds |
US7196161B2 (en) * | 2004-10-01 | 2007-03-27 | Scynexis Inc. | 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection |
WO2007041631A1 (en) * | 2005-09-30 | 2007-04-12 | Scynexis, Inc. | ARYIiALKYL AND HETEROARYLALKYL DERIVATIVES OF CYCLOSPORINE A FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTION |
EP1933859A2 (de) * | 2005-09-30 | 2008-06-25 | Scynexis, Inc. | Verfahren und pharmazeutische zusammensetzungen zur behandlung und prävention von hepatitis-c-infektionen |
CN101511357B (zh) * | 2006-05-19 | 2011-11-02 | 西尼克斯公司 | 环孢菌素类化合物及其组合物在制备治疗和预防眼部疾病的药物中的应用 |
WO2008069917A2 (en) * | 2006-11-20 | 2008-06-12 | Scynexis, Inc. | Novel cyclic peptides |
US20080255038A1 (en) * | 2007-04-11 | 2008-10-16 | Samuel Earl Hopkins | Pharmaceutical compositions |
WO2009148615A1 (en) * | 2008-06-06 | 2009-12-10 | Scynexis, Inc. | Cyclosporin analogs and their use in the treatment of hcv infections |
WO2010002428A2 (en) * | 2008-06-06 | 2010-01-07 | Scynexis, Inc. | Novel macrocyclic peptides |
CN102307892A (zh) * | 2008-12-31 | 2012-01-04 | 西尼克斯公司 | 环孢菌素a的衍生物 |
JP2012514606A (ja) * | 2009-01-07 | 2012-06-28 | サイネクシス,インコーポレーテッド | Hcv治療のためのシクロスポリン誘導体およびヌクレオシドの配合 |
SG172848A1 (en) * | 2009-01-07 | 2011-08-29 | Scynexis Inc | Cyclosporine derivative for use in the treatment of hcv and hiv infection |
EP2509615A1 (de) * | 2009-12-09 | 2012-10-17 | Scynexis, Inc. | Neue cyclische peptide |
-
2005
- 2005-09-30 RU RU2007116119/04A patent/RU2399628C2/ru not_active IP Right Cessation
- 2005-09-30 ES ES05815625T patent/ES2373450T3/es active Active
- 2005-09-30 PT PT05815625T patent/PT1802650E/pt unknown
- 2005-09-30 JP JP2007534872A patent/JP5139065B2/ja not_active Expired - Fee Related
- 2005-09-30 EP EP05815625A patent/EP1802650B1/de not_active Not-in-force
- 2005-09-30 DK DK05815625.8T patent/DK1802650T3/da active
- 2005-09-30 KR KR1020077009820A patent/KR101309409B1/ko not_active IP Right Cessation
- 2005-09-30 CN CN2010100010787A patent/CN101773661B/zh active Active
- 2005-09-30 NZ NZ554514A patent/NZ554514A/en not_active IP Right Cessation
- 2005-09-30 WO PCT/US2005/035533 patent/WO2006039668A2/en active Application Filing
- 2005-09-30 CA CA2583494A patent/CA2583494C/en not_active Expired - Fee Related
- 2005-09-30 MX MX2007003538A patent/MX2007003538A/es active IP Right Grant
- 2005-09-30 SI SI200531452T patent/SI1802650T1/sl unknown
- 2005-09-30 PL PL05815625T patent/PL1802650T3/pl unknown
- 2005-09-30 AT AT05815625T patent/ATE530561T1/de active
- 2005-09-30 BR BRPI0516737-0A patent/BRPI0516737A/pt not_active IP Right Cessation
- 2005-09-30 AU AU2005292162A patent/AU2005292162B2/en not_active Ceased
-
2007
- 2007-03-29 IL IL182315A patent/IL182315A/en not_active IP Right Cessation
-
2008
- 2008-03-07 HK HK08102690.1A patent/HK1108703A1/xx not_active IP Right Cessation
-
2009
- 2009-12-21 US US12/643,860 patent/US20100167996A1/en not_active Abandoned
-
2012
- 2012-05-08 JP JP2012106395A patent/JP2012167113A/ja active Pending
- 2012-06-20 US US13/528,165 patent/US20120264679A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2006039668A2 (en) | 2006-04-13 |
DK1802650T3 (da) | 2012-02-06 |
WO2006039668A3 (en) | 2007-04-19 |
US20120264679A1 (en) | 2012-10-18 |
JP2012167113A (ja) | 2012-09-06 |
HK1108703A1 (en) | 2008-05-16 |
AU2005292162A1 (en) | 2006-04-13 |
CN101773661B (zh) | 2013-09-25 |
EP1802650A2 (de) | 2007-07-04 |
CA2583494C (en) | 2014-01-21 |
KR101309409B1 (ko) | 2013-09-23 |
ES2373450T3 (es) | 2012-02-03 |
CA2583494A1 (en) | 2006-04-13 |
JP2008514732A (ja) | 2008-05-08 |
PL1802650T3 (pl) | 2012-04-30 |
SI1802650T1 (sl) | 2012-03-30 |
NZ554514A (en) | 2010-10-29 |
EP1802650B1 (de) | 2011-10-26 |
RU2399628C2 (ru) | 2010-09-20 |
MX2007003538A (es) | 2008-01-16 |
JP5139065B2 (ja) | 2013-02-06 |
KR20070073841A (ko) | 2007-07-10 |
CN101773661A (zh) | 2010-07-14 |
AU2005292162B2 (en) | 2011-11-10 |
IL182315A0 (en) | 2007-07-24 |
WO2006039668B1 (en) | 2007-05-31 |
PT1802650E (pt) | 2011-12-30 |
BRPI0516737A (pt) | 2008-04-29 |
US20100167996A1 (en) | 2010-07-01 |
EP1802650A4 (de) | 2008-08-20 |
IL182315A (en) | 2013-08-29 |
RU2007116119A (ru) | 2008-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE530561T1 (de) | 3-ether- und 3-thioether-substituierte ciclosporinderivate zur behandlung und prävention einer hepatitis-c-infektion | |
ATE498630T1 (de) | Arylalkyl- und heteroarylalkyl-derivate von cyclosporin a bei der behandlung und vorbeugung einer virusinfektion | |
WO2007041632A3 (en) | Methods and pharmaceutical compositions for the treatment and prevention of hepatitis c infection | |
EP2041159B8 (de) | Makrozyklische verbindungen als antivirale mittel | |
NO20091704L (no) | Inhibitorer av hepatitt C virus | |
NO20091707L (no) | Inhibitorer av hepatitt C virus | |
ATE547103T1 (de) | Hemmer des hepatitis-c-virus | |
EA200901241A1 (ru) | Соединения для лечения гепатита с | |
CY1114356T1 (el) | Αναστολεις του ιου της ηπατιτιδας c | |
NO20091706L (no) | Inhibitorer av hepatitt C virus | |
ATE522532T1 (de) | Verbindungen zur behandlung von hepatitis c | |
EA200900298A1 (ru) | Ингибиторы вируса гепатита с | |
WO2008021936A3 (en) | Hepatitis c virus inhibitors | |
MX2010005292A (es) | Inhibidores de la replicacion del virus de la inmunodeficiencia humana. | |
EA201001273A1 (ru) | Ингибиторы вируса гепатита с | |
MY164469A (en) | Hcv ns3 protease inhibitors | |
CY1109671T1 (el) | Αναστολεις της πρωτεασης ns3 του hcv | |
IL180495A (en) | Benzyl triazolone compounds as non-nucleotide reverse transcriptase inhibitors | |
ATE494291T1 (de) | Verbindungen zur behandlung von hepatitis c | |
DK2250163T3 (da) | Hepatitis C-virusinhibitorer | |
ATE551343T1 (de) | Tetracyclische verbindungen zur behandlung von hepatitis c | |
IL195025A (en) | History of compressed indolubenzazepine with cyclopropyl and pharmaceuticals containing them as an anti-hcv drug | |
ATE402180T1 (de) | Verbindungen zur behandlung von dyslipidemie | |
ATE505473T1 (de) | Cyclopropylkondensierte indolobenzazepinderivate zur behandlung von hepatitis c | |
MX2010001416A (es) | Compuesto para el tratamiento de la hepatitis c. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1802650 Country of ref document: EP |